Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Treace Medical Concepts (TMCI) Change in Inventory (2020 - 2025)

Treace Medical Concepts' Change in Inventory history spans 6 years, with the latest figure at -$5.4 million for Q4 2025.

  • For Q4 2025, Change in Inventory fell 23.81% year-over-year to -$5.4 million; the TTM value through Dec 2025 reached -$3.2 million, down 132.21%, while the annual FY2025 figure was -$3.2 million, 132.21% down from the prior year.
  • Change in Inventory reached -$5.4 million in Q4 2025 per TMCI's latest filing, down from -$973000.0 in the prior quarter.
  • In the past five years, Change in Inventory ranged from a high of $6.6 million in Q1 2024 to a low of -$5.4 million in Q4 2025.
  • Average Change in Inventory over 5 years is $1.4 million, with a median of $2.1 million recorded in 2022.
  • Peak YoY movement for Change in Inventory: skyrocketed 8745.16% in 2022, then plummeted 6401.49% in 2024.
  • A 5-year view of Change in Inventory shows it stood at $31000.0 in 2021, then surged by 8745.16% to $2.7 million in 2022, then plummeted by 102.44% to -$67000.0 in 2023, then tumbled by 6401.49% to -$4.4 million in 2024, then dropped by 23.81% to -$5.4 million in 2025.
  • Per Business Quant, the three most recent readings for TMCI's Change in Inventory are -$5.4 million (Q4 2025), -$973000.0 (Q3 2025), and $4.5 million (Q2 2025).